You are currently viewing a new version of our website. To view the old version click .
Journal of Personalized Medicine
  • Retraction
  • Open Access

31 December 2024

RETRACTED: Chung et al. Long-Lasting Exendin-4-Loaded PLGA Nanoparticles Ameliorate Cerebral Ischemia/Reperfusion Damage in Diabetic Rats. J. Pers. Med. 2022, 12, 390

,
,
,
and
1
Department of Life Science, School of Life Science, College of Science, National Taiwan Normal University, No. 88, Tingzhou Road, Taipei City 116, Taiwan
2
Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan
3
Department of Nursing, College of Healthcare & Management, Asia Eastern University of Science and Technology, New Taipei City 220, Taiwan
4
General Education Center, Asia Eastern University of Science and Technology, New Taipei City 220, Taiwan
This article belongs to the Section Omics/Informatics
The Journal retracts the article “Long-Lasting Exendin-4-Loaded PLGA Nanoparticles Ameliorate Cerebral Ischemia/Reperfusion Damage in Diabetic Rats” [], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding inappropriate image modification and duplication between this publication [] and previously published article [].
Adhering to our standard procedure, the Editorial Office and Editorial Board conducted an investigation that confirmed overlap of sub-images between Figure 4A published in [] and sub-images in Figure 7 from [], the repetition of certain regions within Figure 4C in [] and their overlap with sub-images from Figure 3 in [], as well as image duplication within Figure 10 in []. While the authors fully cooperated with the Editorial Office during the investigation, they were unable to satisfactorily explain the above mentioned concerns nor provide replacement figures and meet the required quality standards to consider a correction as per the journal’s original image requirements policy (https://www.mdpi.com/journal/jpm/instructions#oriimages). As a result, the Editorial Board has lost confidence in the reliability of the findings and decided to retract this publication [], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the Journal of Personalized Medicine.
The authors agreed to this retraction.

References

  1. Chung, C.-H.; Chung, S.-D.; Cheng, Y.-H.; Yang, C.-P.; Chien, C.-T. RETRACTED: Long-Lasting Exendin-4-Loaded PLGA Nanoparticles Ameliorate Cerebral Ischemia/Reperfusion Damage in Diabetic Rats. J. Pers. Med. 2022, 12, 390. [Google Scholar] [CrossRef] [PubMed]
  2. Chien, C.-T.; Jou, M.-J.; Cheng, C.-H.; Yang, C.-H.; Yu, T.-Y.; Li, P.-C. Exendin-4-loaded PLGA microspheres relieve cerebral ischemia/reperfusion injury and neurologic deficits through long-lasting bioactivity-mediated phosphorylated Akt/eNOS signaling in rats. J. Cereb. Blood Flow Metab. 2015, 35, 1790–1803. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.